Yahoo!   My Yahoo!   Mail  
Search   
Sign In
New User? Sign Up
Home > Investing > ROSG > Summary

More on ROSG

Rosetta Genomics, Ltd.
(ROSG)

1.61USD   Down 0.04 (2.42%)   
At 2:29AM IST
 Rosetta Genomics, Ltd. (NGM:ROSG) Delayed quote data 
[Chart]
1d  5d  3m  6m  1y  2y  5y 
Last Trade: 1.61USD
Trade Time:2:29AM IST
Change:Down 0.04 (2.42%) 
Prev Close:1.65
Open:1.62
Bid:1.38 x 3500
Ask:N/A
1y Target Est:N/A
Day's Range:1.59 - 1.67
52wk Range:1.59 - 3.80
Volume:46,247
Avg Vol (3m):90,725.4
Market Cap:22.82M
P/E (ttm):N/A
EPS (ttm):-0.87
Div & Yield:N/A (N/A%)
Add ROSG to Portfolio   Download Data

HEADLINES

 
•Rosetta Genomics Announces Issuance of Three U.S. Patents - Business Wire  - Wed, Feb 3
•Rosetta Genomics Fortifies Patent Position with U.S. Allowance of Claims Covering Human microRNAs miR-21 and hcmv-miR-UL112 - Business Wire  - Fri, Jan 29
•Rosetta Genomics Ltd. Closes $5.1 Million Financing; Will Support Ongoing Development of microRNA-based Diagnostic Pipeline - Business Wire  - Wed, Jan 20
•Medifast, Rosetta Genomics: Biggest Price Decliners (MED, ROSG) - The Wall Street Journal Online  - Fri, Jan 15
•LaBranche, Rosetta Genomics: Early Volume Plays - TheStreet.com  - Thu, Jan 14
•Rosetta Genomics Ltd. to Raise $5.1 Million in Registered Direct Offering - Business Wire  - Thu, Jan 14
•Rosetta Announces that Johns Hopkins University Researchers Demonstrate miRview squamous Classifies Non-Small Cell Lung Cancer with Extremely High Degree of Accuracy - Business Wire  - Wed, Jan 13
•Rosetta Genomics Stockholders Elect Two New Directors at Annual Meeting - Business Wire  - Wed, Dec 23
•ROSETTA GENOMICS LTD Earnings, Business Update & Pipeline Progress Call scheduled for 8:30 am ET today - CCBN  - Fri, Dec 18
•Rosetta Genomics Reports Third Quarter Financial Results, Provides Business Update - Business Wire  - Fri, Dec 18
» More Headlines for ROSG...

ANALYST

 
EPS Est (next year) () :N/A
EPS Est (in 2 years) () :N/A
Avg Rec (current)*:N/A
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
» Analyst Opinion» Estimates

BUSINESS SUMMARY

 
Rosetta Genomics Ltd. develops microRNA-based diagnostic and therapeutic products in Israel. MicroRNAs are naturally expressed, or produced, using instructions encoded in DNA and are used in regulating protein production.

» Full Company Profile